Carsten Claussen brings his extensive leadership experience to European ScreeningPort. He has wide executive management experience, including as CEO of Evotec Technologies, now part of PerkinElmer, Inc., and as Member of Evotec AG’s Executive Management Committee. Carsten is Guest Professor for Entrepreneurship and sits on the boards of several start-up companies.

Philip Gribbon is responsible for Operations and Science at European ScreeningPort. He brings considerable experience in drug discovery programs across a wide range of target classes acquired while working at Pfizer and GSK. Philip has a PhD in Biophysics from Imperial College, London.

Sheraz Gul joined European ScreeningPort after 7 years experience of drug discovery within GlaxoSmithKline ranging from target validation, developing assays for screening, compound profiling, lead optimisation and candidate characterisation. He has a BSc, PhD and 5 years postdoctoral research from the University of London and is the co-author of several high ranking publications and the Enzyme Assays: Essential Data handbook.

Mira Grättinger is in charge of Business Development and Marketing at the European ScreeningPort. She previously established the assay development and screening department at a Munich biotech company before taking over responsibility for their Business Development. She holds a diploma in biology and a PhD in biochemistry from the Universities of Regensburg and Hamburg.

Francoise Halley brings her 5 years expertise in High-Content assay development to European ScreeningPort. She previously worked for Cenix Bioscience using High-Throughput RNAi technology for the discovery and pre-clinical development of novel therapeutics. Francoise has a Master in Biotechnology from the Ecole Nationale Superieure de Technologie des Biomolecules de Bordeaux (ENSTBB), France.

Jörn-Benjamin Lenz comes to the European ScreeningPort directly from University of Hamburg and holds degrees in pharmacy and bioinformatics. At the European ScreeningPort he is in charge of discovery and screening informatics and also contributes his knowledge in pharmacology.

Matthias Rath contributes his expertise in Bioinformatics and Information Technology to the European ScreeningPort team. Matthias comes to European ScreeningPort from c.a.r.u.s. Information Technology AG. He holds a PhD in Chemistry from the University of Kiel.

Jeanette Reinshagen is biological-technical assistant with 2 years of working experience in the assay development and cell culture team of a biotech company. She joined European ScreeningPort in 2009 to contribute to the assay development and screening department.

Nina Viertel is in charge of commercial affairs at European ScreeningPort. In parallel she is completing her degree in European Business Administration and Management at the European Business University of Applied Sciences of Hamburg and working for c.a.r.u.s. Information Technology AG.

Markus Wolf comes to European ScreeningPort after 2 years stationed at the University of Cincinnati to set up a screening laboratory and train personnel to use HTS equipment. He previously worked for both Evotec and PerkinElmer running and maintaining screening systems used for drug discovery.